Zoetis Inc. Business Combination, Consideration Transferred
Zoetis Inc. (ZTS) reported Business Combination, Consideration Transferred of $254.00 million for the 0-month period ending 2015-02-10, per its 10-Q filed 2015-08-06.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation
us-gaap:BusinessCombinationConsiderationTransferred1 · last filed 2015-08-06
- Zoetis Inc. business combination, consideration transferred for fiscal 2014 was $255.00M.
| Period end | Business Combination, Consideration Transferred 0 month | Business Combination, Consideration Transferred 0 month as first filed | Business Combination, Consideration Transferred 12 month |
|---|---|---|---|
| 2015-02-10 | $254.00M 10-Q · filed 2015-08-06 | $255.00M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $255.00M 10-K · filed 2015-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |